Skip to search formSkip to main contentSkip to account menu

fowlpox-TRICOM vaccine

Known as: Recombinant Fowlpox-TRICOM, rF-TRICOM (B7.1.iCAM1-LFA3-Fowlpox), Recombinant Fowlpox-TRICOM Vaccine 
A vaccine comprised of a recombinant fowlpox virus vector encoding a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM), which may… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Purpose: Interleukin (IL)-2 therapy is currently used for therapy of renal cell carcinoma (RCC). However, it is only effective in… 
Highly Cited
2006
Highly Cited
2006
Successful immunotherapy of established tumors depends on overcoming the suppressive influence of the local tumor… 
2005
2005
The efficacy of antigen-specific CD8+ CTLs depends not only on the quantity of CTLs generated but also perhaps, more importantly… 
2004
2004
Dendritic cells (DCs) are the most potent of the antigen-presenting cells (APCs). Preparation of sufficient numbers of mature DCs… 
Highly Cited
2002
Highly Cited
2002
By virtue of its tissue-specific expression, carcinoembryonic antigen (CEA) is an important self, tumor-associated antigen, which… 
Highly Cited
2001
Highly Cited
2001
T-cell activation usually requires at least two signals. The first signal is antigen-specific, and the second signal(s) involves… 
2001
2001
  • M. Morse
  • Current opinion in molecular therapeutics
  • 2001
  • Corpus ID: 37668406
Therion Biologics, the NCI and Aventis Pasteur are investigating CEA-TRICOM, a recombinant, pox virus-based vaccine that…